Search Results 1551-1560 of 19218 for Neutrophil

1. Neurosurgery - Clinical trials

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

2. A Study of LOXO-292 in Patients with Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.0 × 109/L not requiring growth factor support for at least 7 days prior to treatment, and; Platelet count ≥ 75 × 109/L ...

3. Publications - David L. Murray, M.D., Ph.D. - Mayo Clinic

   ... neutrophil cytoplasmic antibody associated vasculitis. Rheumatology (Oxford). 2018 Apr 1; 57 (4):639-650. View PubMed; Genzen JR, Murray DL, Abel G, Meng QH ...

4. Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. - Mayo Clinic

   Absolute neutrophil count ≥1.5 x 109/L; 2. Hemoglobin ≥9 g/dL: transfusion to achieve this cutoff is not allowed within 14 days of first dose of study ...

5. Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 - Mayo Clinic

   - Absolute neutrophil count ≥1.5 × 109/L - Platelet count ≥75 × 109/L - Hemoglobin ≥9 g/dL - Left ventricular ejection fraction (LVEF) ≥50% measured by ...

6. Clinical trials - Oncology (Medical)

   MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

7. A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies - Mayo Clinic

   Participation eligibility · Absolute neutrophil count (ANC); · For monotherapy and pembrolizumab combination therapy cohorts: ≥ 1000/µL; · For PLD combination ...

8. Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer - Mayo Clinic

   ECOG performance status of 0 or 1. 6. Patient has adequate bone marrow and organ function, as defined by the following laboratory values: 1. Absolute neutrophil ...

9. Oral AMXT 1501 Dicaprate in Combination With IV DFMO - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.5 × 10^9/L without granulocyte colony-stimulating factor (G-CSF) support within 7 days preceding the lab assessment; ...

10. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

    Absolute Neutrophil count (ANC) ≥1.5 x10^9 /L (without granulocute coloty-stimulating support);; Absolute Lymphocyte count (ALC) ≥ 0.5 x 10^9 /L ...